Adicet Bio, Inc. (ACET) has a consensus analyst rating of Buy, based on 12 analysts covering the stock. Of those, 9 recommend buying, 3 recommend holding, and 0 recommend selling.
The analyst consensus price target for ACET is $18.00, representing a +157.1% upside from the current price of $7. Price targets range from a low of $18.00 to a high of $18.00.
